Comparing two drugs in participants having hairless patches and noting the outcome as hair regrowth seen in the participants after 3 months of completing treatment.
Not Applicable
- Conditions
- Health Condition 1: L639- Alopecia areata, unspecified
- Registration Number
- CTRI/2024/06/068994
- Lead Sponsor
- Dr Vaishnavi Puri
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients willing to give consent.
Patients of alopecia areata with more than equal to 3 patches or scalp area involving more than 10% .
Exclusion Criteria
1)Patients who have received topical and systemic medications for alopecia areata upto 1 month before.
2) Pregnant and lactating women.
3) Patients with history of active TB or incompletely treated TB.
4) Patients with psychiatric illness.
5) Patients with HIV, Hepatitis B and Malignancy.
6) History of serious side effects to phosphodiesterase type 4 inhibitors – Apremilast.
7) Patients with severe renal impairment, hepatic impairment cardiac diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method